Clarivate has included Timo Müller in this year’s list of Highly Cited Researchers. The Director of the Institute for Diabetes and Obesity (IDO) is recognized in the Cross-Field category.
Research on Obesity and Diabetes
Müller's research focuses on developing new pharmacological treatments for obesity and diabetes. A particular emphasis is placed on investigating metabolic hormones such as GLP-1 and GIP and their potential for treating these conditions.
“Hormone-based therapeutics have fundamentally transformed the treatment of metabolic diseases in recent years. I am very pleased that our work is contributing to this progress,” says Timo Müller.
About the Highly Cited Researchers
The annual Highly Cited Researchers list recognizes scientists who have demonstrated significant influence in their respective research fields. The selection is based, among other criteria, on publications that rank among the top 1% most cited worldwide in their respective fields and publication years. Clarivate also considers additional quantitative and qualitative criteria in its evaluation.